Severity classifications are essential for many diseases to prioritize patient management tasks such as diagnosis, treatment, and follow-up.
Primary aldosteronism (PA), a common cause of secondary hypertension, lacks a standardized severity scale despite generally requiring invasive diagnostics like adrenal venous sampling (AVS).
This study aimed to develop a global expert consensus-based classification for PA severity to improve clinical decision-making.
